165 related articles for article (PubMed ID: 7903830)
21. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex. Multicenter AIDS Cohort Study.
Lyles RH; Chu C; Mellors JW; Margolick JB; Detels R; Giorgi JV; Al-Shboul Q; Phair JP
AIDS; 1999 Feb; 13(3):341-9. PubMed ID: 10199224
[TBL] [Abstract][Full Text] [Related]
22. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.
Masur H; Ognibene FP; Yarchoan R; Shelhamer JH; Baird BF; Travis W; Suffredini AF; Deyton L; Kovacs JA; Falloon J
Ann Intern Med; 1989 Aug; 111(3):223-31. PubMed ID: 2546472
[TBL] [Abstract][Full Text] [Related]
23. CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection.
Kovacs A; Frederick T; Church J; Eller A; Oxtoby M; Mascola L
JAMA; 1991 Apr; 265(13):1698-703. PubMed ID: 1672169
[TBL] [Abstract][Full Text] [Related]
24. [Pneumocystis pneumonia in HIV-infected patients with cytomegalovirus co-infection. Two case reports and a literature review].
Polaczek MM; Zych J; Oniszh K; Szopiński J; Grudny J; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2014; 82(5):458-66. PubMed ID: 25133815
[TBL] [Abstract][Full Text] [Related]
25. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
Klatt EC; Nichols L; Noguchi TT
Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
[TBL] [Abstract][Full Text] [Related]
26. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
27. [Clinical characteristics and T-lymphocyte subsets in 48 acquired immune deficiency syndrome patients with cytomegalovirus infections].
Jia CH; Wang L; Jing FH; Xie J; Qiu ZF; Li TS; Lyu W
Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):191-197. PubMed ID: 30803177
[No Abstract] [Full Text] [Related]
28. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
29. Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy.
Fischl MA; Olson RM; Follansbee SE; Lalezari JP; Henry DH; Frame PT; Remick SC; Salgo MP; Lin AH; Nauss-Karol C; Lieberman J; Soo W
Ann Intern Med; 1993 May; 118(10):762-9. PubMed ID: 8097082
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project.
Sullivan PS; Hanson DL; Chu SY; Jones JL; Ward JW
Blood; 1998 Jan; 91(1):301-8. PubMed ID: 9414298
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
32. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
[TBL] [Abstract][Full Text] [Related]
33. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
[TBL] [Abstract][Full Text] [Related]
34. [CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection].
Miró JM; Buira E; Mallolas J; Gallart T; Moreno A; Zamora L; Vilella R; Gatell JM; Soriano E
Med Clin (Barc); 1994 Apr; 102(15):566-70. PubMed ID: 7646597
[TBL] [Abstract][Full Text] [Related]
35. CD8+ T lymphocyte counts as an adjunctive predictor of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Oka S; Nagata Y; Fujino Y; Yasuoka A; Ishihara M; Ikeda K; Iwamoto A; Shimada K; Mochizuki M; Kimura S
Intern Med; 1997 Jul; 36(7):461-5. PubMed ID: 9240493
[TBL] [Abstract][Full Text] [Related]
36. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
37. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
J Infect Dis; 1992 Dec; 166(6):1223-7. PubMed ID: 1358986
[TBL] [Abstract][Full Text] [Related]
38. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia.
Koziel H; Kim S; Reardon C; Li X; Garland R; Pinkston P; Kornfeld H
Am J Respir Crit Care Med; 1999 Dec; 160(6):2048-55. PubMed ID: 10588627
[TBL] [Abstract][Full Text] [Related]
39. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
40. Current status of therapy for human immunodeficiency virus type 1.
Lane HC
Curr Opin Immunol; 1992 Aug; 4(4):486-9. PubMed ID: 1356350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
